Filing Details
- Accession Number:
- 0001104659-25-061810
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-23 18:34:51
- Reporting Period:
- 2025-03-03
- Filing Date:
- 2025-06-23
- Accepted Time:
- 2025-06-23 18:34:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 2019410 | Caris Life Sciences Inc. | CAI | Services-Medical Laboratories (8071) | 852077369 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2071923 | Russel John Denton | C/O Caris Life Sciences, Inc. 750 W. John Carpenter Freeway, Suite 800 Irving TX 75039 | See Remarks | No | Yes | No | No |
Transaction Summary
| Purchased: | 7,500 shares | Avg. Price: $21.00 | Total Value: $157,500.00 |
| Number of Shares After Transactions: | 123,591 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-03-03 | 238,230 | $18.60 | 16,770 | No | 4 | D | Direct | |
| Common Stock | Acquisiton | 2025-06-18 | 99,321 | $0.00 | 116,091 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2025-06-20 | 7,500 | $21.00 | 123,591 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | D | Direct | |
| No | 4 | A | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Acquisiton | 2025-03-03 | 255,000 | $0.00 | 255,000 | $18.60 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 255,000 | 2035-03-03 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,000 | Indirect | By Trust |
Footnotes
- Represents shares of Common Stock surrendered to the Issuer as repayment for an outstanding promissory note.
- These securities were previously reported on the Reporting Person's Form 3. All the securities reported in this Form 4 reflect a one-for-four reverse stock split effected as of June 1, 2025.
- Represents an award of restricted stock units which vest in accordance with the applicable grant agreement.
- The stock option vested 60% at grant and will vest 20% on September 1, 2025 and 20% on September 1, 2026. These securities were previously reported on the Reporting Person's Form 3.
Billionaire Hedge Funds
